These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 3315583

  • 1. Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
    Bonnier JJ.
    Drugs; 1987; 33 Suppl 3():151-3. PubMed ID: 3315583
    [Abstract] [Full Text] [Related]

  • 2. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    Bonnier HJ, Visser RF, Klomps HC, Hoffmann HJ.
    Am J Cardiol; 1988 Jul 01; 62(1):25-30. PubMed ID: 3289357
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.
    Anderson JL, Rothbard RL, Hackworthy RA, Sorensen SG, Fitzpatrick PG, Dahl CF, Hagan AD, Browne KF, Symkoviak GP, Menlove RL.
    J Am Coll Cardiol; 1988 Jun 01; 11(6):1153-63. PubMed ID: 3284943
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
    Brochier ML, Quilliet L, Kulbertus H, Materne P, Letac B, Cribier A, Monassier JP, Sacrez A, Favier JP.
    Drugs; 1987 Jun 01; 33 Suppl 3():140-5. PubMed ID: 3315581
    [Abstract] [Full Text] [Related]

  • 9. Fibrinogen concentration and coronary artery reperfusion after intravenous anisoylated plasminogen streptokinase activator complex or intracoronary streptokinase therapy.
    Marder VJ, Kinsella PA, Brown MJ.
    Drugs; 1987 Jun 01; 33 Suppl 3():237-41. PubMed ID: 3315601
    [Abstract] [Full Text] [Related]

  • 10. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Timmis AD, Griffin B, Crick JC, Flax JS, Sowton E.
    Drugs; 1987 Jun 01; 33 Suppl 3():146-50. PubMed ID: 3315582
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of 2 intravenous thrombolytic agents (anisoylated plasminogen streptokinase activator complex versus streptokinase) in patients with acute myocardial infarction.
    Seabra-Gomes R, Aniceto Silva J, Aleixo A, Real T, Freire I, Torres I, Freitas R, Crespo F.
    Drugs; 1987 Jun 01; 33 Suppl 3():169-74. PubMed ID: 3315586
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Summary of early clinical experience with anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarction.
    Jackson D.
    Drugs; 1987 Jun 01; 33 Suppl 3():104-11. PubMed ID: 3315574
    [Abstract] [Full Text] [Related]

  • 17. Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Kasper W, Meinertz T, Wollschläger H, Bonzel T, Chen C, Hofmann T, Zeiher A, Drexler H, Just H.
    Drugs; 1987 Jun 01; 33 Suppl 3():112-6. PubMed ID: 3315575
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study.
    Renkin J, Beys CC, Lavenne-Pardonge E, Pintens H, Col J.
    Drugs; 1987 Jun 01; 33 Suppl 3():253-60. PubMed ID: 3315603
    [Abstract] [Full Text] [Related]

  • 20. Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.
    Rothbard RL, Anderson JL, Fitzpatrick PG, Hakworthy RA, Sorensen SG, Marder VJ.
    Clin Cardiol; 1990 Mar 01; Suppl 5():V11-4; discussion V27-32. PubMed ID: 2182234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.